139 related articles for article (PubMed ID: 1336073)
1. Abnormal lipid and lipoprotein patterns in liver cirrhosis with and without hepatocellular carcinoma.
Ahaneku JE; Taylor GO; Olubuyide IO; Agbedana EO
J Pak Med Assoc; 1992 Nov; 42(11):260-3. PubMed ID: 1336073
[TBL] [Abstract][Full Text] [Related]
2. Changes in plasma high density lipoprotein cholesterol and phospholipid in acute viral hepatitis and cholestatic jaundice.
Ahaneku JE; Olubuyide IO; Agbedana EO; Taylor GO
J Intern Med; 1991 Jan; 229(1):17-21. PubMed ID: 1995758
[TBL] [Abstract][Full Text] [Related]
3. Serum lipids in hepatoma.
Alsabti EA
Oncology; 1979; 36(1):11-4. PubMed ID: 221872
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein (a) behaviour in patients with hepatocellular carcinoma.
Motta M; Giugno I; Ruello P; Pistone G; Di Fazio I; Malaguarnera M
Minerva Med; 2001 Oct; 92(5):301-5. PubMed ID: 11675573
[TBL] [Abstract][Full Text] [Related]
5. Serum selenium concentration in patients with liver cirrhosis and hepatocellular carcinoma.
Buljevac M; Romić Z; Vucelić B; Banić M; Krznarić Z; Plesko S
Acta Med Croatica; 1996; 50(1):11-4. PubMed ID: 8776109
[TBL] [Abstract][Full Text] [Related]
6. Plasma lipidomic fingerprinting to distinguish among hepatitis C-related hepatocellular carcinoma, liver cirrhosis, and chronic hepatitis C using MALDI-TOF mass spectrometry: a pilot study.
Passos-Castilho AM; Lo Turco E; Ferraz ML; Matos C; Silva I; Parise E; Pilau E; Gozzo F; Granato C
J Gastrointestin Liver Dis; 2015 Mar; 24(1):43-9. PubMed ID: 25822433
[TBL] [Abstract][Full Text] [Related]
7. Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis.
Cicognani C; Malavolti M; Morselli-Labate AM; Zamboni L; Sama C; Barbara L
Arch Intern Med; 1997 Apr; 157(7):792-6. PubMed ID: 9125012
[TBL] [Abstract][Full Text] [Related]
8. Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients.
Carr BI; Giannelli G; Guerra V; Giannini EG; Farinati F; Rapaccini GL; Marco MD; Zoli M; Caturelli E; Masotto A; Virdone R; Sacco R; Trevisani F
Int J Biol Markers; 2018 Nov; 33(4):423-431. PubMed ID: 29874983
[TBL] [Abstract][Full Text] [Related]
9. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
[TBL] [Abstract][Full Text] [Related]
10. Serum lipids & lipoprotein profiles of cigarette smokers & passive smokers.
Whig J; Singh CB; Soni GL; Bansal AK
Indian J Med Res; 1992 Oct; 96():282-7. PubMed ID: 1459670
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the concentrations of plasma phospholipid stearic acid and plasma lipoprotein lipids in healthy men.
Li D
Clin Sci (Lond); 2001 Jan; 100(1):25-32. PubMed ID: 11115414
[TBL] [Abstract][Full Text] [Related]
12. Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease.
Newsome PN; Beldon I; Moussa Y; Delahooke TE; Poulopoulos G; Hayes PC; Plevris JN
Aliment Pharmacol Ther; 2000 Oct; 14(10):1295-301. PubMed ID: 11012474
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of simple non-invasive liver fibrosis indices for predicting hepatocellular carcinoma (HCC) among Egyptian patients.
Abdelgawad IA
J Clin Pathol; 2015 Feb; 68(2):154-60. PubMed ID: 25430496
[TBL] [Abstract][Full Text] [Related]
14. [Changes in the lipid profile in chronic hepatopathies].
Perales J; Angel Lasunción M; Cano A; Martín-Scapa MA; Matíes M; Herrera E
Med Clin (Barc); 1994 Mar; 102(10):364-8. PubMed ID: 8182981
[TBL] [Abstract][Full Text] [Related]
15. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
16. May plasma cholesterol level be considered a neoplastic marker in liver disease from cirrhosis to hepatocellular carcinoma?
Venturini I; Amedei R; Modonesi G; Cosenza R; Miglioli L; Cioni G; Zeneroli ML
Ital J Gastroenterol Hepatol; 1999; 31(1):61-5. PubMed ID: 10091105
[TBL] [Abstract][Full Text] [Related]
17. Plasma amino acid levels in patients with colorectal cancers and liver cirrhosis with hepatocellular carcinoma.
Lee JC; Chen MJ; Chang CH; Tiai YF; Lin PW; Lai HS; Wang ST
Hepatogastroenterology; 2003; 50(53):1269-73. PubMed ID: 14571716
[TBL] [Abstract][Full Text] [Related]
18. Elevation of serum type IV collagen in liver cancer as well as liver cirrhosis.
Hong WS; Hong SI; Park SY; Son Y; Lee YS; Chung YH; Yang SK; Suh DJ; Min YI
Anticancer Res; 1995; 15(6B):2777-80. PubMed ID: 8669863
[TBL] [Abstract][Full Text] [Related]
19. Plasma proteosome level as a potential marker for hepatocellular carcinoma.
Salama HM; Abdel-Haleem H; Taha FM; Abdel-Azeez RA; Marzaban RN; El-Nahaas SM; Darwish T
Arab J Gastroenterol; 2013 Sep; 14(3):87-93. PubMed ID: 24206735
[TBL] [Abstract][Full Text] [Related]
20. Effect of cyclosporin A on serum lipids in primary biliary cirrhosis patients.
Parsons HG; Thirsk JE; Frohlich J; Dias V; Minuk GY
Clin Invest Med; 1989 Dec; 12(6):386-91. PubMed ID: 2612091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
